Keeping Current CME

Latest Episodes:

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations Dec 15, 2023

Show notes

How well do you understand the challenges that patients face with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer with a high risk for recurrence?

Credit available for this activity expires: 12/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999101?ecd=bdc_podcast_libsyn_mscpedu

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies Dec 14, 2023

Show notes

Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing?

Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice Dec 12, 2023

Show notes

Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing.

Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999024?ecd=bdc_podcast_libsyn_mscpedu

From Symptom to Solution: Best Practices in Syndromic Testing for Improved Patient Outcomes Dec 11, 2023

Show notes

Do you know how to appropriately incorporate syndromic testing into patient care? Hear from the experts. Credit available for this activity expires: [12/11/24] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999156 ?ecd=bdc_podcast_libsyn_mscpedu

Novel Biologic Therapies for Spondyloarthritis: The Year in Review Dec 08, 2023

Show notes

Are you up to date on latest data on biologics in spondyloarthritis and the recent EULAR treatment recommendation updates? Join us to find out more!

Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998991?ecd=bdc_podcast_libsyn_mscpedu

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors Dec 06, 2023

Show notes

Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998747?ecd=bdc_podcast_libsyn_mscpedu

Personalizing Risk Assessment to Enhance Primary Cardiovascular Prevention: From Methods to Interpretation Dec 05, 2023

Show notes

Join our experts to hear about imaging strategies to determine cardiovascular (CV) risk and optimum preventive strategies. Credit available for this activity expires: 12/5/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998954?ecd=bdc_podcast_libsyn_mscpedu

Nonalcoholic Steatohepatitis: Mission Possible! Dec 04, 2023

Show notes

Learn to recognize, diagnose, and manage nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 12/4/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998939?ecd=bdc_podcast_libsyn_mscpedu

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer Dec 01, 2023

Show notes

View the experts discuss the ins and outs of immunotherapy for advanced non-small cell lung cancer (NSCLC) in the real world. Credit available for this activity expires: 11/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998874?ecd=bdc_podcast_libsyn_mscpedu

ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes Nov 30, 2023

Show notes

How confident are you in managing patients your patients on ROS1 inhibitor therapy?

Credit available for this activity expires: 11/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998606?ecd=bdc_podcast_libsyn_mscpedu

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected